Table 1.
Trait | (% SE) | (%) | (% SE) | (% SE) | (% SE) | Enrichmenta(SE) | |
---|---|---|---|---|---|---|---|
BMI1 | 16.5 (0.5) | 4223 | 0.39 | 1.6 (0.001) | 3.1 (0.1) | 3.1 (0.1) | 3.7 (0.4) |
Height2 | 59.4 (0.3) | 6923 | 0.86 | 13.9 (0.002) | 32.0 (0.2) | 24.0 (0.2) | 1.5 (0.1) |
Hemoglobin24 | 17.9 (2.1) | 3725 | 0.48 | 2.2 (0.003) | 1.9 (0.3) | 1.8 (0.3) | 7.6 (1.4) |
Mean cell hemoglobin24 | 29.3 (2.2) | 5226 | 0.56 | 7.2 (0.003) | 6.2 (0.4) | 6.1 (0.4) | 9.9 (1.9) |
Concentration of mean cell hemoglobin24 | 10.9 (2.5) | 4827 | 0.23 | 0.4 (0.003) | 0.5 (0.2) | 0.5 (0.2) | 6.7 (1.8) |
Mean cell volume24 | 26.3 (2.0) | 5226 | 0.51 | 6.5 (0.004) | 5.7 (0.4) | 5.6 (0.4) | 8.1 (1.3) |
Packed cell volume24 | 16.7 (2.5) | 3025 | 0.56 | 1.4 (0.003) | 0.9 (0.2) | 0.8 (0.2) | 6.0 (1.4) |
Red blood cell count24 | 22.0 (2.3) | 5626 | 0.39 | 3.6 (0.004) | 2.6 (0.3) | 2.6 (0.3) | 6.4 (1.6) |
Number of platelets28 | 27.5 (1.5) | 5725 | 0.48 | 3.5 (0.003) | 3.9 (0.3) | 3.9 (0.3) | 5.7 (0.9) |
Fasting glucose29 | 22.3 (2.3) | 6630 | 0.34 | 2.6 (0.002) | 1.7 (0.2) | 1.6 (0.2) | 8.0 (2.5) |
Fasting insulin29 | 19.9 (2.4) | 3631 | 0.55 | – | – | – | – |
HBA1C32 | 20.8 (2.3) | 7530 | 0.28 | 1.8 (0.003) | 0.9 (0.2) | 0.9 (0.2) | 6.6 (1.9) |
HOMA-B29 | 20.3 (2.4) | 7233 | 0.28 | 0.6 (0.001) | 0.4 (0.1) | 0.4 (0.1) | 7.5 (1.9) |
HOMA-IR29 | 19.9 (2.4) | 3831 | 0.52 | – | – | – | – |
HDL3 | 39.4 (0.9) | 4234 | 0.94 | 5.8 (0.002) | 10.7 (0.2) | 10.5 (0.2) | 4.6 (1.3) |
LDL3 | 33.0 (1.0) | 4034 | 0.82 | 7.8 (0.002) | 8.4 (0.2) | 8.3 (0.2) | 5.1 (0.9) |
TC3 | 35.5 (0.9) | 5035 | 0.71 | 8.0 (0.002) | 9.3 (0.2) | 9.3 (0.2) | 4.3 (0.6) |
TG3 | 34.8 (0.9) | 4036 | 0.87 | 5.2 (0.002) | 8.0 (0.2) | 8.0 (0.2) | 5.8 (1.4) |
Education years37 | 19.9 (0.8) | 4037 | 0.50 | 0.1 (0.002) | 0.2 (0.0) | 0.2 (0.0) | 3.2 (1.4) |
Forearm BMD38 | 17.4 (2.2) | 8439 | 0.21 | 0.3 (0.001) | 0.5 (0.1) | 0.5 (0.1) | 22.4 (7.7) |
Femoral-neck BMD38 | 24.1 (2.1) | 8439 | 0.29 | 2.0 (0.003) | 2.0 (0.2) | 2.0 (0.2) | 7.1 (1.0) |
Lumbar spine38 | 25.1 (2.0) | 8439 | 0.30 | 2.2 (0.003) | 2.2 (0.3) | 2.2 (0.3) | 6.1 (0.8) |
Age at menarche40 | 27.8 (0.7) | 4941 | 0.57 | 2.6 (0.002) | 3.8 (0.2) | 3.7 (0.2) | 2.9 (0.2) |
College37 | 19.4 (0.8) | 4037 | 0.48 | 0.1 (0.001) | 0.1 (0.0) | 0.1 (0.0) | 3.5 (0.9) |
RA42 | 66.3 (0.9) | 5543 | 1.21 | 11.2 (0.003) | 22.0 (0.3) | 22.1 (0.3) | 9.8 (4.3) |
SCZ44 | 64.5 (0.7) | 8145 | 0.80 | 6.2 (0.004) | 9.2 (0.2) | 9.2 (0.2) | 2.3 (0.1) |
Crohn disease46 | 35.9 (1.8) | 5347 | 0.68 | 3.8 (0.002) | 5.9 (0.4) | 5.9 (0.4) | 4.8 (0.7) |
Inflammatory bowel disease46,b | 35.3 (1.4) | – | – | 4.9 (0.002) | 6.7 (0.3) | 6.6 (0.3) | 4.6 (0.5) |
Ulcerative colitis46 | 31.9 (2.1) | 5847 | 0.55 | 2.7 (0.002) | 4.1 (0.3) | 4.1 (0.3) | 5.4 (1.0) |
Type 2 diabetes48 | 25.4 (1.6) | 2649 | 0.98 | 1.3 (0.002) | 1.1 (0.2) | 1.1 (0.2) | 3.9 (0.7) |
is the same as except that GWAS index SNPs were excluded from the computation. In Table S2, we report , which we obtained by excluding all GWAS hits. We also report estimates of familial heritability obtained from twin or family studies. At the bottom of the table, we list case-control traits where our estimate of is biased as a result of ascertainment.
Similar to Finucane et al.,7 we define enrichment as the ratio between the fraction of attributable to and the genomic fraction covered by these loci. We obtained SEs by a jackknife over the loci.
Inflammatory bowel disease refers to the union of Crohn disease and ulcerative colitis.